{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:17:59Z","timestamp":1766157479147},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Human immunodeficiency virus type 1 (HIV-1) infection frequently causes neurologic disease, which is the result of viral replication and activation of macrophages and microglia in the CNS, and subsequent secretion of high levels of neurotoxic products, including tumor necrosis factor-\u03b1 (TNF-\u03b1). We therefore hypothesized that a soluble TNF-\u03b1 antagonist might have potential utility as a neuroprotective effecter molecule, and conducted proof-of-concept studies to test this hypothesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To develop novel therapeutics for the treatment of neuroAIDS, we constructed and characterized a soluble TNF receptor (sTNFR)-Fc fusion protein with the goal of neutralizing TNF-\u03b1, and tested the stability of expression of this gene following delivery by a lentiviral vector.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>High-titer lentiviral vectors were prepared, allowing efficient transduction of macrophage\/glial and neuronal cell lines, as well as primary rat cerebellar neurons. Efficient, stable secretion of sTNFR-Fc was demonstrated in supernatants from transduced cell lines over 20 passages, using both western blot and ELISA. Biological activity of the secreted sTNFR-Fc was confirmed by TNF-specific<jats:italic>in vitro<\/jats:italic>protein binding and functional blocking assays. Finally, the secreted protein was shown to protect neuronal cells from TNF-\u03b1, HIV-1 Tat-, and gp120-mediated neurotoxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results demonstrate that lentiviral vector mediated expression of sTNFR-Fc may have potential as a novel therapy for neuroAIDS.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1742-2094-8-48","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T06:14:46Z","timestamp":1305612886000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS"],"prefix":"10.1186","volume":"8","author":[{"given":"Shengbo","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn F","family":"Sniderhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay B","family":"Maggirwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Dewhurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,14]]},"reference":[{"issue":"6","key":"361_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/archneurol.2010.84","volume":"67","author":"JC McArthur","year":"2010","unstructured":"McArthur JC, Steiner J, Sacktor N, Nath A: Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Annals of Neurology. 2010, 67 (6): 699-714. 10.1001\/archneurol.2010.84.","journal-title":"Annals of Neurology"},{"issue":"23","key":"361_CR2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010, 75 (23): 2087-2096. 10.1212\/WNL.0b013e318200d727.","journal-title":"Neurology"},{"key":"361_CR3","volume-title":"J Neurovirol","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, for the CHARTER and HNRC Groups: HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2010."},{"key":"361_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","volume":"42","author":"RA Kroll","year":"1998","unstructured":"Kroll RA, Neuwelt EA: Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery. 1998, 42: 1083-1099. 10.1097\/00006123-199805000-00082.","journal-title":"Neurosurgery"},{"key":"361_CR5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1046\/j.1471-4159.2001.00222.x","volume":"76","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Pardridge WM: Rapid transferrin efflux from brain to blood across the blood-brain barrier. J Neurochem. 2001, 76: 1597-1600. 10.1046\/j.1471-4159.2001.00222.x.","journal-title":"J Neurochem"},{"key":"361_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/35073667","volume":"410","author":"M Kaul","year":"2001","unstructured":"Kaul M, Garden GA, Lipton SA: Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 2001, 410: 988-994. 10.1038\/35073667.","journal-title":"Nature"},{"key":"361_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1046\/j.1365-2362.2002.01029.x","volume":"32","author":"M Van de Bovenkamp","year":"2002","unstructured":"Van de Bovenkamp M, Nottet HS, Pereira CF: Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1-associated dementia. Eur J Clin Invest. 2002, 32: 619-627. 10.1046\/j.1365-2362.2002.01029.x.","journal-title":"Eur J Clin Invest"},{"key":"361_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0898-6568(01)00262-5","volume":"14","author":"DJ MacEwan","year":"2002","unstructured":"MacEwan DJ: TNF receptor subtype signaling: differences and cellular consequences. Cell Signal. 2002, 14: 477-492. 10.1016\/S0898-6568(01)00262-5.","journal-title":"Cell Signal"},{"key":"361_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/oso\/9780198526100.003.0014","volume-title":"The Neurology of AIDS","author":"HS Nottet","year":"2005","unstructured":"Nottet HS: The blood brain barrier: monocyte and viral entry into the brain. The Neurology of AIDS. Edited by: Gendelman HE, Grant I, Everall IP, Lipton SA, Swindells S. 2005, Oxford, UK: Oxford University Press, 155-161. 2","edition":"2"},{"key":"361_CR10","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1073\/pnas.92.16.7162","volume":"92","author":"E Bonfoco","year":"1995","unstructured":"Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-Daspartate or nitric oxide\/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 1995, 92: 7162-7166. 10.1073\/pnas.92.16.7162.","journal-title":"Proc Natl Acad Sci USA"},{"key":"361_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/89490","volume":"4","author":"P Bezzi","year":"2001","unstructured":"Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A: CXCR4-activated astrocyte glutamate release via TNF-alpha: amplification by microglia triggers neurotoxicity. Nat Neurosci. 2001, 4: 702-710. 10.1038\/89490.","journal-title":"Nat Neurosci"},{"key":"361_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.10828","volume":"55","author":"NJ Haughey","year":"2004","unstructured":"Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, Mattson MP: Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol. 2004, 55: 257-267. 10.1002\/ana.10828.","journal-title":"Ann Neurol"},{"key":"361_CR13","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1046\/j.1471-4159.2003.01942.x","volume":"86","author":"RN Saha","year":"2003","unstructured":"Saha RN, Pahan K: Tumor necrosis factor-alpha at the crosroads of neuronal life and death during HIV-associated dementia. J Neurochem. 2003, 86: 1057-1071. 10.1046\/j.1471-4159.2003.01942.x.","journal-title":"J Neurochem"},{"key":"361_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/13550289809114529","volume":"4","author":"B Shi","year":"1998","unstructured":"Shi B, Raina J, Lorenzo A, Busciglio J, Gabuzda D: Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol. 1998, 4: 281-290. 10.3109\/13550289809114529.","journal-title":"J Neurovirol"},{"key":"361_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3940(02)01006-6","volume":"333","author":"V Chaparro-Huerta","year":"2002","unstructured":"Chaparro-Huerta V, Rivera-Cervantes MC, Torres-Mendoza BM, Beas-Z\u00e1rate C: Neuronal death and tumor necrosis factor-alpha response to glutamate-induced excitotoxicity in the cerebral cortex of neonatal rats. Neurosci Lett. 2002, 333: 95-98. 10.1016\/S0304-3940(02)01006-6.","journal-title":"Neurosci Lett"},{"issue":"12","key":"361_CR16","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/sj.gt.3300785","volume":"5","author":"RA Mageed","year":"1998","unstructured":"Mageed RA, Adams G, Woodrow D, Podhajcer OL, Chernajovsky Y: Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor. Gene Ther. 1998, 5 (12): 1584-1592. 10.1038\/sj.gt.3300785.","journal-title":"Gene Ther"},{"issue":"15","key":"361_CR17","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.gt.3301985","volume":"10","author":"JM Kim","year":"2003","unstructured":"Kim JM, Ho SH, Hahn W, Jeong JG, Park EJ, Lee HJ, Yu SS, Lee CS, Lee YW, Kim S: Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein. Gene Ther. 2003, 10 (15): 1216-1224. 10.1038\/sj.gt.3301985.","journal-title":"Gene Ther"},{"issue":"3","key":"361_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00221-005-2307-9","volume":"165","author":"MA Williams","year":"2005","unstructured":"Williams MA, Turchan J, Lu Y, Nath A, Drachman DB: Protection of human cerebral neurons from neurodegenerative insults by gene delivery of soluble tumor necrosis factor p75 receptor. Exp Brain Res. 2005, 165 (3): 383-391. 10.1007\/s00221-005-2307-9.","journal-title":"Exp Brain Res"},{"key":"361_CR19","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.4049\/jimmunol.164.5.2776","volume":"164","author":"JL Croxford","year":"2000","unstructured":"Croxford JL, Triantaphyllopoulos KA, Neve RM, Feldmann M, Chernajovsky Y, Baker D: Gene Therapy for Chronic Relapsing Experimental Allergic Encephalomyelitis Using Cells Expressing a Novel Soluble p75 Dimeric TNF Receptor. J Immunol. 2000, 164: 2776-2781.","journal-title":"J Immunol"},{"issue":"2","key":"361_CR20","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1186\/ar1036","volume":"6","author":"DJ Gould","year":"2004","unstructured":"Gould DJ, Bright C, Chernajovsky Y: Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid. Arthritis Res Ther. 2004, 6 (2): R103-113. 10.1186\/ar1036.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"361_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jgm.1053","volume":"9","author":"M Khoury","year":"2007","unstructured":"Khoury M, Adriaansen J, Vervoordeldonk MJ, Gould D, Chernajovsky Y, Bigey P, Bloquel C, Scherman D, Tak PP, Jorgensen C, Apparailly F: Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis. J Gene Med. 2007, 9 (7): 596-604. 10.1002\/jgm.1053.","journal-title":"J Gene Med"},{"issue":"1","key":"361_CR22","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/ar2113","volume":"9","author":"D Gould","year":"2007","unstructured":"Gould D, Yousaf N, Fatah R, Subang MC, Chernajovsky Y: Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis. Arthritis Res Ther. 2007, 9 (1): R7-10.1186\/ar2113.","journal-title":"Arthritis Res Ther"},{"key":"361_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/jgm.825","volume":"8","author":"L Zeng","year":"2006","unstructured":"Zeng L, Planelles V, Sui Z, Gartner S, Maggirwar SB, Dewhurst S, Ye L, Nerurkar VR, Yanagihara R, Lu Y: HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1. J Gene Med. 2006, 8: 18-28. 10.1002\/jgm.825.","journal-title":"J Gene Med"},{"key":"361_CR24","first-page":"67","volume":"53","author":"C Wu","year":"2007","unstructured":"Wu C, Lu Y: Inclusion of high molecular weight dextran in calcium phosphate-mediated transfection significantly improves gene transfer efficiency. Cell Mol Biol (Noisy-le-grand). 2007, 53: 67-74.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"361_CR25","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1099\/vir.0.020255-0","volume":"91","author":"C Wu","year":"2010","unstructured":"Wu C, Lu Y: High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages. J Gen Virol. 2010, 91: 1909-1918. 10.1099\/vir.0.020255-0.","journal-title":"J Gen Virol"},{"key":"361_CR26","first-page":"15","volume":"11","author":"ME Jeffrey","year":"1988","unstructured":"Jeffrey ME, Armstrong LS, Martinez AO: A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures. Methods Cell Sci. 1988, 11: 15-17.","journal-title":"Methods Cell Sci"},{"key":"361_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"Hiroyuki Mizuguchi","year":"2000","unstructured":"Mizuguchi Hiroyuki, Xu Zhili, Ishii-Watabe Akiko, Uchida Eriko, Hayakawa Takao: IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther. 2000, 1: 376-382. 10.1006\/mthe.2000.0050.","journal-title":"Mol Ther"},{"key":"361_CR28","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.1073\/pnas.87.21.8331","volume":"87","author":"T Kohno","year":"1990","unstructured":"Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL: A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA. 1990, 87: 8331-8335. 10.1073\/pnas.87.21.8331.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"28","key":"361_CR29","doi-asserted-by":"publisher","first-page":"17852","DOI":"10.1074\/jbc.273.28.17852","volume":"273","author":"DR New","year":"1998","unstructured":"New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA: HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J Biol Chem. 1998, 273 (28): 17852-17858. 10.1074\/jbc.273.28.17852.","journal-title":"J Biol Chem"},{"issue":"3","key":"361_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.nbd.2007.03.004","volume":"26","author":"L Buscemi","year":"2007","unstructured":"Buscemi L, Ramonet D, Geiger JD: Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol Dis. 2007, 26 (3): 661-670. 10.1016\/j.nbd.2007.03.004.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"361_CR31","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.4049\/jimmunol.164.12.6538","volume":"164","author":"M Mayne","year":"2000","unstructured":"Mayne M, Holden CP, Nath A, Geiger JD: Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J Immunol. 2000, 164 (12): 6538-6542.","journal-title":"J Immunol"},{"key":"361_CR32","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1097\/00001756-200012180-00014","volume":"11","author":"U Englund","year":"2000","unstructured":"Englund U, Ericson C, Rosenblad C, Mandel RJ, Trono D, Wictorin K, Lundberg C: The use of a recombinant lentiviral vector for ex vivo gene transfer into the rat CNS. Neuroreport. 2000, 11: 3973-3977. 10.1097\/00001756-200012180-00014.","journal-title":"Neuroreport"},{"issue":"1","key":"361_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.410320104","volume":"32","author":"M Tardieu","year":"1992","unstructured":"Tardieu M, H\u00e9ry C, Peudenier S, Boespflug O, Montagnier L: Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol. 1992, 32 (1): 11-17. 10.1002\/ana.410320104.","journal-title":"Ann Neurol"},{"issue":"12","key":"361_CR34","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1097\/00002030-199712000-00006","volume":"11","author":"HC Chang","year":"1997","unstructured":"Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B: HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS. 1997, 11 (12): 1421-1431. 10.1097\/00002030-199712000-00006.","journal-title":"AIDS"},{"issue":"2","key":"361_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/1531-8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3","volume":"47","author":"A Nath","year":"2000","unstructured":"Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD: Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol. 2000, 47 (2): 186-194. 10.1002\/1531-8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3.","journal-title":"Ann Neurol"},{"key":"361_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1046\/j.1471-4159.1999.0730578.x","volume":"73","author":"SB Maggirwar","year":"1999","unstructured":"Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S: HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem. 1999, 73: 578-586.","journal-title":"J Neurochem"},{"issue":"36","key":"361_CR37","doi-asserted-by":"publisher","first-page":"22385","DOI":"10.1074\/jbc.272.36.22385","volume":"272","author":"P Chen","year":"1997","unstructured":"Chen P, Mayne M, Power C, Nath A: The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem. 1997, 272 (36): 22385-22388. 10.1074\/jbc.272.36.22385.","journal-title":"J Biol Chem"},{"issue":"3","key":"361_CR38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1128\/jvi.70.3.1384-1389.1996","volume":"70","author":"K Conant","year":"1996","unstructured":"Conant K, Ma M, Nath A, Major EO: Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol. 1996, 70 (3): 1384-1389.","journal-title":"J Virol"},{"issue":"3","key":"361_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.nbd.2007.03.004","volume":"26","author":"L Buscemi","year":"2007","unstructured":"Buscemi L, Ramonet D, Geiger JD: Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol Dis. 2007, 26 (3): 661-670. 10.1016\/j.nbd.2007.03.004.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"361_CR40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.nbd.2006.05.005","volume":"3","author":"S Theodore","year":"2006","unstructured":"Theodore S, Cass WA, Nath A, Steiner J, Young K, Maragos WF: Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Neurobiol Dis. 2006, 3 (3): 663-668.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"361_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00002030-199509020-00004","volume":"9","author":"MC Yeung","year":"1995","unstructured":"Yeung MC, Pulliam L, Lau AS: The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS. 1995, 9 (2): 137-143.","journal-title":"AIDS"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-8-48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T19:05:18Z","timestamp":1712430318000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-8-48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-8-48","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,14]]},"assertion":[{"value":"24 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"48"}}